Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT03813147

Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Bone Marrow Diseases, Hematologic Diseases, +11 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 19 locations
View Trial Details
Completed

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

NCT00588991

Conditions
Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +55 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Completed

Observational Study Towards the Impact of Newly Started Treatment in MDS on QoL

NCT04053933

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • Imelda Bonheiden, Antwerpen, Belgium
  • AZ KLINA Brasschaat, Antwerpen, Belgium
  • Sint-Dimpna Ziekenhuis Geel Geel, Antwerpen, Belgium
  • Heilig Hart Ziekenhuis Lier, Antwerpen, Belgium
View all 21 locations
View Trial Details
Completed

Testing the Safety and Efficacy of the Combination of the Antibody Pembrolizumab and Entinostat in Patients With Myelodysplastic Syndrome Who Are Not Responding to Hypomethylating Agents

NCT02936752

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Northwestern University Chicago, Illinois, United States
View all 19 locations
View Trial Details
Completed

Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications

NCT02649790

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Bone Marrow Diseases, +33 more
Locations
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Oncology Institute of Hope and Innovation Pasadena, California, United States
  • Rocky Mountain Regional VA Medical Center Aurora, Colorado, United States
  • Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute) Denver, Colorado, United States
View all 46 locations
View Trial Details
Completed

APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant

NCT03931291

Conditions
Acute Myeloid Leukemia or Myelodysplastic Syndromes, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Johns Hopkins, Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions